Deaths caused by this disease more than tripled between 2017 to 2019 and it is now the fastest rising cause of cancer deaths ...

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...

PBC is a rare and chronic liver disease that disproportionately affects women. The condition causes the small bile ducts in ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

Non-alcoholic fatty liver disease (NAFLD) has emerged as a growing concern in liver cancer development. This condition, often ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.

Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces liver fat ... Liver Transplant Outperforms Other Therapies for ...

hepatic ischemia-reperfusion injury (HIRI), and chronic conditions like nonalcoholic fatty liver disease (NAFLD) and ...

Acute-on-chronic liver failure (ACLF) is a life-threatening condition characterized by acute deterioration of liver function ...

Novo Nordisk A/S’s Wegovy helped treat an obesity-associated liver disease in a late-stage trial, potentially adding to its ...